Logo image of LGCB

LINKAGE GLOBAL INC (LGCB) Stock Fundamental Analysis

USA - NASDAQ:LGCB - KYG5500B1288 - Common Stock

1.72 USD
-0.22 (-11.34%)
Last: 10/22/2025, 10:32:35 AM
Fundamental Rating

2

Taking everything into account, LGCB scores 2 out of 10 in our fundamental rating. LGCB was compared to 30 industry peers in the Broadline Retail industry. The financial health of LGCB is average, but there are quite some concerns on its profitability. LGCB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LGCB has reported negative net income.
LGCB had a negative operating cash flow in the past year.
LGCB Yearly Net Income VS EBIT VS OCF VS FCFLGCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

LGCB has a worse Return On Assets (-3.38%) than 70.00% of its industry peers.
The Return On Equity of LGCB (-6.27%) is worse than 63.33% of its industry peers.
Industry RankSector Rank
ROA -3.38%
ROE -6.27%
ROIC N/A
ROA(3y)0.74%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LGCB Yearly ROA, ROE, ROICLGCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 20 30

1.3 Margins

LGCB has a Gross Margin (40.49%) which is comparable to the rest of the industry.
LGCB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LGCB Yearly Profit, Operating, Gross MarginsLGCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

LGCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LGCB has been increased compared to 1 year ago.
Compared to 1 year ago, LGCB has an improved debt to assets ratio.
LGCB Yearly Shares OutstandingLGCB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 500K 1M 1.5M 2M
LGCB Yearly Total Debt VS Total AssetsLGCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 3.94 indicates that LGCB is not in any danger for bankruptcy at the moment.
LGCB has a better Altman-Z score (3.94) than 66.67% of its industry peers.
LGCB has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
LGCB has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 3.94
ROIC/WACCN/A
WACC6.11%
LGCB Yearly LT Debt VS Equity VS FCFLGCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

LGCB has a Current Ratio of 2.73. This indicates that LGCB is financially healthy and has no problem in meeting its short term obligations.
LGCB has a Current ratio of 2.73. This is amongst the best in the industry. LGCB outperforms 90.00% of its industry peers.
A Quick Ratio of 2.72 indicates that LGCB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.72, LGCB belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.72
LGCB Yearly Current Assets VS Current LiabilitesLGCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

LGCB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.66%, which is quite impressive.
The Revenue for LGCB has decreased by -19.19% in the past year. This is quite bad
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%163.64%
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGCB Yearly Revenue VS EstimatesLGCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LGCB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGCB Price Earnings VS Forward Price EarningsLGCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LGCB indicates a slightly more expensive valuation: LGCB is more expensive than 73.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 90.96
LGCB Per share dataLGCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LGCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LINKAGE GLOBAL INC

NASDAQ:LGCB (10/22/2025, 10:32:35 AM)

1.72

-0.22 (-11.34%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.93%
Inst Owner ChangeN/A
Ins Owners82.06%
Ins Owner ChangeN/A
Market Cap19.20M
Revenue(TTM)10.29M
Net Income(TTM)-440000
AnalystsN/A
Price TargetN/A
Short Float %1.02%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.87
P/FCF N/A
P/OCF N/A
P/B 2.62
P/tB 2.62
EV/EBITDA 90.96
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.92
BVpS0.66
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.38%
ROE -6.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)0.74%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 8
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.72
Altman-Z 3.94
F-Score4
WACC6.11%
ROIC/WACCN/A
Cap/Depr(3y)198.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%163.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.77%
OCF growth 3YN/A
OCF growth 5YN/A